MARKETS
Cord Blood Banks
Due to the promise of using hematopoietic stem cells obtained
from cord blood to treat blood and immune system related
diseases, the cord blood banking industry has experienced
tremendous interest, with new public and private cord blood
banks opening every year.
Since the first successful cord blood transplant was performed
in 1988, thousands of patients have received transplants from
cells derived from cord blood.
In 2006, the Syndey Cord Blood Bank published the results of an
independent comparison of our CryoStor CS5 and CryoStor CS10 and
a cryopreservation media formulation of 10% DMSO in dextran-40.
Results
Cells frozen with CryoStorTM in 10% DMSO had significantlyimproved NC (P<0.001), CD34+ recovery, viable CD34+ (P<0.001) and CFU numbers (P<0.001) compared with dextran in 10% DMSO.
CryoStorTM in 5% DMSO resulted in significantly improved
NC (P<0.001) and CFU (P<0.001).
Read about the superior results our products enabled here.